Brind.
  1. The FDA recommended advancement for a new drug application submitted by a company.

Revelation Biosciences is submitting successful Phase 2/3 trial data for a proprietary drug candidate to the U.S. Food and Drug Administration.

1 report, 1 independent Updated Aug 31
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Revelation Biosciences is submitting successful Phase 2/3 trial data for a proprietary drug candidate to the U.S. Food and Drug Administration.

Who's involved

What this event is mainly about
Gemini

Keep exploring

Part of

The FDA recommended advancement for a new drug application submitted by a company. All 2 developments

The entities involved

  • Gemini

    Chicano rapper

    Nothing else this week.

Coverage

Newest first; wire copies grouped